UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Role of Nursing in the Delivery of Cardio-Oncology

Current treatment options in oncology, 2024-10, Vol.25 (10), p.1268-1275

2024

Volltextzugriff (PDF)

Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia

Blood advances, 2020-02, Vol.4 (3), p.530-538

2020

Volltextzugriff (PDF)

Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia

Leukemia research, 2016-08, Vol.47, p.78-83

2016

Volltextzugriff (PDF)

ubiquitin ligase XBAT32 regulates lateral root development in Arabidopsis

The Plant journal : for cell and molecular biology, 2004-12, Vol.40 (6), p.996-1006

2004

Volltextzugriff (PDF)

T315I-mutated myeloid sarcoma

Leukemia research reports, 2019-01, Vol.12, p.100184, Article 100184

2019

Volltextzugriff (PDF)

Supporting Adherence to Tyrosine Kinase Inhibitor (TKI) Therapy Among Patients with Chronic Myeloid Leukemia (CML)

Blood, 2017-12, Vol.130, p.5624-5624

2017

Volltextzugriff (PDF)

Phase II study of pegylated liposomal doxorubicin, low‐dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma

American journal of hematology, 2014-01, Vol.89 (1), p.62-67

2014

Volltextzugriff (PDF)

Poster: MPN-391: A Review of Gender Differences in Quality of Life for Hematologic Malignancies

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S234-S234

2021

Volltextzugriff (PDF)

MPN-391: A Review of Gender Differences in Quality of Life for Hematologic Malignancies

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S366-S367

2021

Volltextzugriff (PDF)

Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy

Journal of the advanced practitioner in oncology, 2022-03, Vol.13 (2), p.127-142

2022

Volltextzugriff (PDF)

CLL-322: A Systematic Review of Quality of Life in Chronic Lymphocytic Leukemia Patients throughout the Disease Continuum

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S227-S227

2020

Volltextzugriff (PDF)

A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

Leukemia research, 2018-11, Vol.74, p.89-96

2018

Volltextzugriff (PDF)

A Systematic Review of Cardiovascular Adverse Events in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy and Mitigation Strategies

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S297-S297

2019

Volltextzugriff (PDF)

Clinical Characteristics, Treatment Strategies, and Outcomes for CLL Patients with BTK Mutation; A Single Center Study

Blood, 2023-11, Vol.142 (Supplement 1), p.1911-1911

2023

Volltextzugriff (PDF)

Caring for Patients with Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitor (TKI) Therapy in an Era of Evolving Treatment Goals

Clinical lymphoma, myeloma and leukemia, 2018-09, Vol.18, p.S224-S225

2018

Volltextzugriff (PDF)

Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML

Annals of hematology, 2024-06, Vol.103 (6), p.1941-1945

2024

Volltextzugriff (PDF)

An Integrative Review of Sex Differences in Quality of Life and Symptoms Among Survivors of Hematologic Malignancies

Oncology Nursing Forum, 2023-05, Vol.50 (3), p.299

2023

Volltextzugriff (PDF)

Treatment Free Remission in Patients with Chronic Phase CML: A Single Center Experience

Blood, 2021-11, Vol.138 (Supplement 1), p.3612-3612

2021

Volltextzugriff (PDF)

Incidence of Pleural Effusion with Dasatinib and the Effect of Switching Therapy to Bosutinib in Patients with Chronic Phase CML

Blood, 2021-11, Vol.138 (Supplement 1), p.1484-1484

2021

Volltextzugriff (PDF)

Bosutinib Therapy in Patients With Chronic Myeloid Leukemia: Practical Considerations for Management of Side Effects

Journal of the advanced practitioner in oncology, 2016-03, Vol.7 (2), p.160-175

2016

Volltextzugriff (PDF)

Conventional Real Time Quantitative Polymerase Chain Reaction Method Yields Similar Level of Sensitivity to Digital Droplet Polymerase Chain Reaction for Detection of BCR-ABL p210 Transcripts in Patients with Chronic Phase Chronic Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.3382-3382

2019

Volltextzugriff (PDF)

A Phase II Trial of Ibrutinib and PD-1 Blockade in Asymptomatic High Risk Chronic Lymphocytic Leukemia to Improve Immune Function

Blood, 2019-11, Vol.134 (Supplement_1), p.5483-5483

2019

Volltextzugriff (PDF)

Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Retrospective, Single-Institution Analysis Based on Risk Features and Debulking Strategy with Anti-CD20 Monoclonal Antibody

Blood, 2019-11, Vol.134 (Supplement_1), p.5484-5484

2019

Volltextzugriff (PDF)

Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis

Clinical lymphoma, myeloma and leukemia, 2024-06, Vol.24 (6), p.382-391.e2

2024

Volltextzugriff (PDF)

Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia

Blood, 2018-11, Vol.132 (Supplement 1), p.3150-3150

2018

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(8)
Female
(7)
Hematology
(7)
Male
(7)
Oncology
(7)
Adult
(6)
Meeting Reports
(6)
Middle Aged
(6)
Aged
(5)
Aged, 80 And Over
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Chronic Lymphocytic Leukemia
(3)
Leukemia, Lymphocytic, Chronic, B-Cell - Mortality
(3)
Quality Of Life
(3)
Biomarkers
(2)
Chronic Myeloid Leukemia
(2)
Cll
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Role of Nursing in the Delivery of Cardio-Oncology

Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia

Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia

ubiquitin ligase XBAT32 regulates lateral root development in Arabidopsis

T315I-mutated myeloid sarcoma

Supporting Adherence to Tyrosine Kinase Inhibitor (TKI) Therapy Among Patients with Chronic Myeloid Leukemia (CML)

Phase II study of pegylated liposomal doxorubicin, low‐dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma

Poster: MPN-391: A Review of Gender Differences in Quality of Life for Hematologic Malignancies

MPN-391: A Review of Gender Differences in Quality of Life for Hematologic Malignancies

Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy

CLL-322: A Systematic Review of Quality of Life in Chronic Lymphocytic Leukemia Patients throughout the Disease Continuum

A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

A Systematic Review of Cardiovascular Adverse Events in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy and Mitigation Strategies

Clinical Characteristics, Treatment Strategies, and Outcomes for CLL Patients with BTK Mutation; A Single Center Study

Caring for Patients with Chronic Myeloid Leukemia (CML) Receiving Tyrosine Kinase Inhibitor (TKI) Therapy in an Era of Evolving Treatment Goals

Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML

An Integrative Review of Sex Differences in Quality of Life and Symptoms Among Survivors of Hematologic Malignancies

Treatment Free Remission in Patients with Chronic Phase CML: A Single Center Experience

Incidence of Pleural Effusion with Dasatinib and the Effect of Switching Therapy to Bosutinib in Patients with Chronic Phase CML

Bosutinib Therapy in Patients With Chronic Myeloid Leukemia: Practical Considerations for Management of Side Effects

Conventional Real Time Quantitative Polymerase Chain Reaction Method Yields Similar Level of Sensitivity to Digital Droplet Polymerase Chain Reaction for Detection of BCR-ABL p210 Transcripts in Patients with Chronic Phase Chronic Myeloid Leukemia

A Phase II Trial of Ibrutinib and PD-1 Blockade in Asymptomatic High Risk Chronic Lymphocytic Leukemia to Improve Immune Function

Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Retrospective, Single-Institution Analysis Based on Risk Features and Debulking Strategy with Anti-CD20 Monoclonal Antibody

Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis

Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia

Suchergebnisse filtern